Cargando…

Correction to: Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease

Detalles Bibliográficos
Autores principales:	Fu, Hongyan, Zheng, Ziyao, Zhang, Zhenping, Yang, Yanjuan, Cui, Jieda, Wang, Zhaojun, Xue, Jing, Chi, Shuhong, Cao, Mengshu, Chen, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267250/ https://www.ncbi.nlm.nih.gov/pubmed/36971920 http://dx.doi.org/10.1007/s10067-023-06583-y

Ejemplares similares

Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease
por: Fu, Hongyan, et al.
Publicado: (2023)

Interstitial Lung Disease in Anti-Synthetase Syndrome
por: Kourkouni, Evangelia, et al.
Publicado: (2019)

Anti-synthetase syndrome presenting with interstitial lung disease
por: Athanassiou, Panagiotis, et al.
Publicado: (2017)

Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
por: Rose, Jonathan A., et al.
Publicado: (2022)

Anti-Synthetase Syndrome-Related Interstitial Lung Disease With Anti-PL-12 Antibodies
por: Elferjani, Belqis, et al.
Publicado: (2021)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
por: Nashatyreva, Maria S., et al.
Publicado: (2023)

Acute interstitial pneumonia as first presentation of anti-synthetase syndrome: an atypical case
por: Jan, Kalimullah, et al.
Publicado: (2018)

Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies
por: Jiang, Minna, et al.
Publicado: (2021)

A retired shipyard worker with rapidly progressive pulmonary interstitial fibrosis.
por: Moy, E V, et al.
Publicado: (1999)

Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome
por: Zuo, Yu, et al.
Publicado: (2022)

Quantitative proteomic characterization of lung tissue in idiopathic pulmonary fibrosis
por: Tian, Yaqiong, et al.
Publicado: (2019)

Correction: Normal Lung Quantification in Usual Interstitial Pneumonia Pattern: The Impact of Threshold-based Volumetric CT Analysis for the Staging of Idiopathic Pulmonary Fibrosis
por: Ohkubo, Hirotsugu, et al.
Publicado: (2016)

Acute Onset Anti-Synthetase Syndrome With Pericardial Effusion and Non-Specific Interstitial Pneumonia
por: Shah, Aditya, et al.
Publicado: (2016)

Successful baricitinib treatment of refractory anti‐synthetase syndrome associated with interstitial lung disease
por: Sugino, Keishi, et al.
Publicado: (2023)

Prognostic Value of Serum Osteopontin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Gui, Xianhua, et al.
Publicado: (2020)

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
por: Harari, Sergio
Publicado: (2018)

The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis–Associated Interstitial Lung Disease
por: Martín-López, María, et al.
Publicado: (2023)

Correction: Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
por: Li, Ying, et al.
Publicado: (2013)

Anti-Aminoacyl Transfer-RNA-Synthetases (Anti-tRNA) Autoantibodies Associated with Interstitial Lung Disease: Pulmonary Disease Progression has a Persistent Elevation of the Th17 Cytokine Profile
por: Ramos-Martinez, Espiridión, et al.
Publicado: (2020)

Correction: Quantitative CT analysis of honeycombing area predicts mortality in idiopathic pulmonary fibrosis with definite usual interstitial pneumonia pattern: A retrospective cohort study
por: Nakagawa, Hiroaki, et al.
Publicado: (2019)

Correction to: Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro
por: Wei, Qilu, et al.
Publicado: (2021)

Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
por: Takei, Reoto, et al.
Publicado: (2023)

Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome
por: Ge, Yongpeng, et al.
Publicado: (2020)

A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach
por: Sawal, Naina, et al.
Publicado: (2021)

Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease
por: Zhu, Lili, et al.
Publicado: (2022)

Factors for progressive pulmonary fibrosis in connective tissue disease-related interstitial lung disease
por: Kim, Kyuhwan, et al.
Publicado: (2023)

Plasma Leptin Is Elevated in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Cao, Mengshu, et al.
Publicado: (2016)

Anti-synthetase syndrome-associated pulmonary veno-occlusive disease
por: Kay, Diana, et al.
Publicado: (2020)

Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy
por: Oka, Hideki, et al.
Publicado: (2023)

Correction to: Nonribosomal peptide synthetases and their biotechnological potential in Penicillium rubens
por: Iacovelli, Riccardo, et al.
Publicado: (2022)

Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China
por: Zhan, Xi, et al.
Publicado: (2021)

Anti‐synthetase syndrome associated interstitial lung disease after combination dual immune checkpoint inhibition
por: Bell, Peter T., et al.
Publicado: (2023)

Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
por: Donahoe, Michael, et al.
Publicado: (2015)

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
por: Olson, Amy L., et al.
Publicado: (2018)

The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
por: Cameli, Paolo, et al.
Publicado: (2022)

Correction to: Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
por: Yoshikawa, Takumi, et al.
Publicado: (2020)

Automated Analysis of Crackles in Patients with Interstitial Pulmonary Fibrosis
por: Flietstra, B., et al.
Publicado: (2011)

Mesenchymal cell survival in airway and interstitial pulmonary fibrosis
por: Bonner, James C
Publicado: (2010)

Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond
por: Galindo-Feria, Angeles S., et al.
Publicado: (2022)

Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern
por: Cao, Meng-Shu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rq4ctaeqg4ipfpgkvdcjh0r4pl